P70.3

Clinical Causes: Administration of high doses of insulin or glucose-lowering medications to the mother during pregnancy, which can affect the fetus. Medical treatments during neonatal care, such as insulin therapy for underlying conditions like hyperglycemia. Delayed or inappropriate feeding after birth, especially in infants receiving nutritional support intravenously. Use of medications that influence blood sugar levels given to the mother or the newborn. Medical procedures that inadvertently affect the infant's blood sugar stability during or after delivery.

Key Symptoms: Jitteriness or tremors Lethargy or sluggishness Poor feeding or reluctance to feed Weak cry or irritability Seizures in severe cases Pale or cyanotic skin (bluish discoloration) Unusual breathing patterns

Diagnosis Path: Diagnosis involves measuring the infant's blood glucose levels, often using a heel prick blood sample. Blood tests are performed to confirm hypoglycemia, typically indicated by glucose levels below 45 mg/dL (2.5 mmol/L) in newborns. Additional assessments may include tests to determine the underlying cause, such as blood tests for insulin levels or markers of other metabolic conditions. The baby’s overall health, feeding patterns, and medical history are also considered during diagnosis.

Treatment Protocols: Managing iatrogenic neonatal hypoglycemia involves restoring normal blood sugar levels and addressing the underlying cause. Common treatments include: - Prompt feeding with breast milk or formula to stabilize blood glucose. - Intravenous glucose infusion in cases where oral feeding is insufficient or not feasible. - Monitoring blood glucose levels closely until stability is achieved. - Adjusting or stopping medications or interventions that may contribute to hypoglycemia. - Treating any underlying metabolic or health issues identified during diagnosis. Long-term management may involve follow-up to ensure proper growth and development, and to prevent recurrent episodes. Healthcare providers tailor treatment strategies based on the severity of hypoglycemia and the infant's overall condition, always prioritizing rapid stabilization to prevent neurological damage.